We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$518B
AUM Growth
+$18.2B
Cap. Flow
-$36B
Cap. Flow %
-6.94%
Top 10 Hldgs %
29.96%
Holding
15,912
New
1,749
Increased
6,361
Reduced
6,148
Closed
1,439

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.78B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$973M
3
DIS icon
Walt Disney
DIS
+$588M
4
LLY icon
Eli Lilly
LLY
+$569M
5
T icon
AT&T
T
+$529M

Sector Composition

Rank Sector Weight
1 Technology 3.4%
2 Healthcare 3.08%
3 Financials 2.41%
4 Consumer Discretionary 2.33%
5 Industrials 1.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBE
14351
Obsidian Energy
OBE
$697M
$74 ﹤0.01%
9
-37,923
-100% -$265K
VBIV
14352
PUT
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$60 ﹤0.01%
100
QBTS icon
14353
D-Wave Quantum Inc. Common Stock
QBTS
$7.78B
$59 ﹤0.01%
+29
New +$41
DXYN
14354
PUT
DELISTED
Dixie Group Inc
DXYN
$57 ﹤0.01%
+100
New +$61
GTHX
14355
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$52 ﹤0.01%
12
-43,954
-100% -$153K
CZR icon
14356
Caesars Entertainment
CZR
$6.04B
$44 ﹤0.01%
1
-1,317,350
-100% -$57M
PVLA
14357
PUT
Palvella Therapeutics
PVLA
$2.26B
$37 ﹤0.01%
3
-51
-94% -$710
IVVD icon
14358
Invivyd
IVVD
$202M
$36 ﹤0.01%
+8
New +$33
MI
14359
CALL
NFT Ltd
MI
$1.95M
0
ABEO icon
14360
Abeona Therapeutics
ABEO
$361M
$29 ﹤0.01%
4
-91,116
-100% -$577K
BNKK
14361
Bonk Inc
BNKK
$8.16M
-48
Closed -$4.35K
AGS
14362
DELISTED
PlayAGS
AGS
$27 ﹤0.01%
3
-23,803
-100% -$208K
ASHS icon
14363
Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF
ASHS
$34.7M
$26 ﹤0.01%
+1
New +$26
UAMY icon
14364
PUT
United States Antimony
UAMY
$799M
$25 ﹤0.01%
100
-15,200
-99% -$3.62K
XXII
14365
PUT
22nd Century Group
XXII
$1.42M
0
SMMT icon
14366
Summit Therapeutics
SMMT
$11.2B
$21 ﹤0.01%
+5
New +$20
AVXL icon
14367
Anavex Life Sciences
AVXL
$303M
$20 ﹤0.01%
4
-273,306
-100% -$1.54M
KXIN icon
14368
CALL
Kaixin Holdings
KXIN
$8.47M
0
KXIN icon
14369
PUT
Kaixin Holdings
KXIN
$8.47M
0
FFAI
14370
Faraday Future Intelligent Electric
FFAI
$12M
0
TUP
14371
DELISTED
Tupperware Brands Corporation
TUP
$15 ﹤0.01%
11
-130,235
-100% -$208K
AAU
14372
PUT
DELISTED
Almaden Minerals Ltd
AAU
$14 ﹤0.01%
+100
New +$14
ANVS icon
14373
Annovis Bio
ANVS
$76.1M
$12 ﹤0.01%
+1
New +$11
ANY icon
14374
Sphere 3D
ANY
$18M
$12 ﹤0.01%
+1
New +$20
TPST icon
14375
Tempest Therapeutics
TPST
$18.7M
0

Similar funds

Citadel Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Citadel Advisors held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citadel Advisors withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citadel Advisors opened a new position in TD Synnex worth $245M.

  • Citadel Advisors's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
  • Citadel Advisors added most to Hess in Q1 2024, an estimated $1.28B increase.
  • Citadel Advisors's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
  • Citadel Advisors fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
  • Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
  • Citadel Advisors opened 1,749 new positions and closed 1,439 in Q1 2024.
  • Citadel Advisors's portfolio value rose 3.6% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.